Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Astellas Pharma Inc.

Market Cap 3,820B 23.77B 20.68B 19B 17.89B 33.51B 2,251B 33.91B 224B 87.6B 1,105B 89.27B 87.37B P/E 2026
15.5x
P/E 2027 * 10.9x
Enterprise Value 4,249B 26.44B 23B 21.13B 19.9B 37.27B 2,504B 37.71B 249B 97.43B 1,228B 99.29B 97.17B EV / Sales 2026
2.24x
EV / Sales 2027 * 1.66x
Free-Float
98.88%
Yield 2026
3.1%
Yield 2027 * 3.77%
1 day-0.88%
1 week+0.90%
Current month-7.44%
1 month-8.20%
3 months-12.67%
6 months-0.80%
Current year+0.63%
1 week 11.1
Extreme 11.1
11.9
1 month 11.1
Extreme 11.1
12.3
Current year 11.1
Extreme 11.1
14.19
1 year 7.85
Extreme 7.848
14.19
3 years 7.53
Extreme 7.534
14.93
5 years 7.53
Extreme 7.534
16
10 years 7.53
Extreme 7.534
16.7
Manager TitleAgeSince
Chief Executive Officer 63 10/02/2023
Director of Finance/CFO 54 01/11/2023
Compliance Officer - 01/04/2025
Director TitleAgeSince
Chairman 66 10/02/2023
Director/Board Member 63 01/06/2019
Director/Board Member 69 01/06/2021
Change 5-day change 1-year change 3-year change Capi.($)
-0.88%+0.90% - - 23.94B
-0.94%-2.85%+37.70%+148.38% 1,001B
-0.42%-1.18%+50.88%+42.60% 566B
-0.56%-1.86%+15.91%+59.57% 393B
-1.18%+2.29%+24.04%+16.53% 326B
+1.09%+2.21%+25.56%+33.32% 276B
+1.42%-1.17%+24.53%+14.29% 277B
+1.87%+5.96%-42.67%-48.26% 193B
-1.78%-0.84%+15.60%+48.77% 188B
-1.40%-0.04%+13.19%+59.08% 158B
Average -0.03%+0.35%+18.30%+41.59% 375.2B
Weighted average by Cap. -0.24%-0.41%+27.02%+66.27%

Financials

2026 2027 *
Net sales 2,132B 13.27B 11.54B 10.61B 9.99B 18.7B 1,256B 18.92B 125B 48.89B 616B 49.82B 48.76B 2,244B 13.96B 12.14B 11.16B 10.51B 19.68B 1,322B 19.91B 132B 51.45B 649B 52.43B 51.31B
Net income 296B 1.84B 1.6B 1.47B 1.39B 2.6B 175B 2.63B 17.41B 6.8B 85.71B 6.93B 6.78B 350B 2.18B 1.89B 1.74B 1.64B 3.07B 206B 3.11B 20.54B 8.02B 101B 8.18B 8B
Net Debt 429B 2.67B 2.32B 2.13B 2.01B 3.76B 253B 3.8B 25.16B 9.83B 124B 10.01B 9.8B -103B -639M -556M -511M -481M -901M -60.55B -912M -6.03B -2.36B -29.71B -2.4B -2.35B
Logo Astellas Pharma Inc.
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
Employees
13,643
Date Price Change Volume
17/06/26 11.20 -0.88% 0
16/06/26 11.30 0.00% 0
15/06/26 11.30 -4.24% 1
12/06/26 11.80 +6.31% 425
11/06/26 11.10 -5.93% 0
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
2,132.50JPY
Average target price
2,400.00JPY
Spread / Average Target
+12.54%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!